Eli Lilly
LLY43.0K
$1150.99
▼ 1.64%
None
0
Low
AI Layoff Impact Summary
AI-poweredEli Lilly has no confirmed layoff events on record. WARN filings indicate no active notices. Low risk — company appears stable.
All Posts
Everything in one feed
Internal mobility hit a brick wall
I’ve been trying to transfer internally for three months now. I’ve had great feedback, passed the initial screenings, and then—poof. Everything goes silent. I finally got a straight answer from a recruiter friend in another department who told me there is a silent hiring freeze on all lateral moves across the board. If they aren't letting us move internally, it’s almost certainly to make the math for a reduction in force cleaner on the books. It’s incredibly frustrating because I’m trying to grow my career here, but the writing seems to be on the wall. If you’re currently waiting on an internal offer, I’d suggest looking externally instead. I’ve stopped waiting for them to get back to me and have started reaching out to recruiters at competitors. Better to be prepared than to be the one surprised when the inevitable announcement email hits the inbox.
Is the mid-year 'restructuring' talk actually happening?
Has anyone else noticed an uptick in the vague 'operational efficiency' chatter during skip-level meetings? My manager keeps pivoting away whenever I ask about the Q4 budget allocation, and the sudden shift from growth initiatives to 'prioritizing core deliverables' feels like a classic prelude to something unpleasant. I’ve been here long enough to know that when leadership stops talking about expansion and starts talking about 'streamlining workflows,' the severance packets aren't far behind. My team just had two open headcount slots closed without warning. Is this happening in other divisions, or is my department just being targeted? I’m trying not to spiral, but the lack of transparency is starting to make me look at my LinkedIn and dust off the resume. It feels like the calm before the storm.
Performance review anxiety - is it just me?
The atmosphere in my office feels incredibly heavy lately. We just had our mid-year check-ins and the tone from leadership was significantly more cold and metrics-focused than last year. I’ve been hearing rumors that they are looking to tighten the curve on performance ratings to justify trimming the bottom tier. Is there actually a plan for a RIF (reduction in force) coming, or is management just trying to scare people into putting in more weekend hours? The pressure to hit these impossible quarterly targets is at an all-time high, and people are definitely acting twitchy during meetings. I feel like we're walking on eggshells waiting for a corporate town hall that will inevitably be vague. If anyone has intel on what the internal sentiment is at HQ, please share. I’d rather know now if I should be polishing my resume.
Anyone else noticing the travel freeze?
Is it just my department, or is everyone getting their travel and external training requests denied? I’ve had three separate requests for conferences turned down this month, with the response being 'stringent budget prioritization.' It’s starting to feel a lot like the quiet lead-up to a restructuring announcement. We were told growth was the focus, but the penny-pinching feels like they’re trying to inflate the bottom line for end-of-year reporting. Usually, when the 'discretionary spend' taps get turned off this hard, headcount reductions follow shortly after. Has anyone in the commercial or R&D divisions heard whispers about Q4 budget re-allocations? I don’t want to be caught off guard if they’re planning a 'strategic realignment' to offset the recent heavy investment spend.
Eli Lilly - Project re-scoping, budget scrutiny?
Wondering if anyone else is experiencing a significant increase in budget reviews and project re-scoping across Eli Lilly? I've been hearing a lot more about 'resource optimization' and 'strategic alignment' than usual. It's not just R&D, seems to be hitting other functions too. Some internal initiatives that seemed like sure bets are suddenly on hold or being scaled back. Is this a broader company trend, or am I just in a department that's facing a tougher review cycle? Just trying to gauge the overall atmosphere. Doesn't feel like mass layoffs are imminent, but definitely feels like a shift in how resources are being allocated. Anyone have insights?
Eli Lilly - Signs of a slowdown at Lilly?
Hey everyone. Seeing a lot of chatter and a general 'vibe' that things might be tightening up at Lilly lately. No official word, obviously, but I've noticed a few things in my department. Some hiring freezes on non-critical roles, and a few 're-prioritization' meetings that feel a bit like project pruning. Anyone else in other areas picking up on similar signals? Feels like maybe the massive growth has hit a bit of a plateau, or maybe they're just being super strategic about future investments. Curious to hear if others are seeing the same, or if it's just my corner of the building.
Lilly - Is R&D feeling the pinch?
Been in R&D at Lilly for a while. The buzz lately has been pretty quiet, which is unusual for us. Usually, there's always some new initiative or expansion happening. Now, it feels like a lot of focus is on existing pipelines and optimizing what we have. Heard some chatter about certain early-stage discovery programs being re-evaluated or even shelved. It's not official, of course, but the vibe is definitely one of caution and prioritization. Makes you wonder if the company is preparing for something, or just being extremely prudent with resources. Anyone else in R&D feel this shift? Are you seeing changes in project funding or headcount planning? Trying to get a sense of the broader picture beyond my own corner of the company. Any insights appreciated.
Eli Lilly - Anyone else seeing projects get pushed or delayed?
Hey everyone, Been at Lilly for a few years now, and lately things feel... different. A lot of projects I was involved in, or heard about from other departments, seem to be getting pushed back, sometimes indefinitely. It's not just one or two; it's starting to feel like a pattern. Budgets seem tighter too, with approvals taking longer for even basic things. Just wondering if anyone else is experiencing this or if it's just my team/area? Feels like a hiring freeze might be in effect or at least a significant slowdown. Not hearing direct layoff talk, but the project delays and general caution are definitely making me a bit nervous about what's coming down the pipeline. Curious to hear if others are seeing similar things or if it's just the usual end-of-year crunch magnified. Let me know what you're seeing.
Hiring freezes at Lilly? Or just slow down?
Been seeing a lot of requisitions for my department go dark recently. Some were posted for a while, and then just disappeared without explanation. Also, a couple of roles that were supposed to open up next quarter seem to be on indefinite hold. Is anyone else in recruiting or hiring manager roles at Lilly experiencing a similar situation? Trying to figure out if it's a formal hiring freeze or just a general slowdown across the board. If anyone has insights into the official stance or any internal communication about hiring plans, would appreciate any info. Feels like a shift from the growth phase we've been in.
Lilly - Anyone else hearing whispers about budget cuts?
Hey all, been at Lilly for a few years now, and things have been pretty steady, or so I thought. Lately, I've been hearing some chatter in different teams about tighter budgets and project reviews. It's not overt, but there's a definite feeling of 'belt-tightening' going on. Has anyone else picked up on this? Is it specific to certain divisions, or is this a company-wide vibe? Trying to gauge if this is just my perception or if others are seeing/hearing the same thing. No concrete news, just trying to connect the dots. Curious about what people are thinking out there.
Eli Lilly - Any departments feeling the squeeze?
Been seeing some posts about other pharma companies having a tough time lately and it got me thinking about Lilly. No official word or anything concrete, but I've been hearing whispers through the grapevine, mostly about certain R&D areas and maybe some marketing functions. It's vague, and could just be noise, but I figured it was worth putting out there. Anyone in specific departments notice any hiring freezes, budget cuts, or just a general 'weird vibe' lately? Trying to gauge if there's any specific pain point within the company or if it's just general industry anxiety. My team hasn't seen anything, but I'm in a stable area. Just want to prepare myself and others if there's any truth to it. Any intel from those closer to the ground would be appreciated.
Lilly Leadership Changes & Potential Impact?
Hey everyone, has anyone else noticed the recent shuffle in some of the higher-up positions at Lilly? Saw a few announcements about execs moving around. It's got me wondering if this is just standard corporate churn or if it signals a broader strategic shift. We all know the company is doing well, but sometimes big leadership changes precede a restructuring or, dare I say, workforce adjustments. Not hearing any concrete rumors about layoffs specifically, but the timing feels… interesting. Curious to hear if anyone in the know has any insights or if I'm just overthinking it. Feels like the pharma world is always in flux, but this feels a bit more pointed. Just trying to get a pulse on what might be coming down the pipeline. Anyone else picking up on anything?
Eli Lilly - Rumors swirling about restructuring?
Okay, I've been trying to ignore it, but the whispers about potential layoffs or significant restructuring at Lilly are getting louder. It's not just one or two people saying it; it's popping up in different pockets of the company. I haven't seen any official communication, but the internal job postings have been weirdly quiet lately, and there's been a lot of talk about 'strategic realignment.' Anyone else in the same boat? Is this just general industry jitters or is there something more specific happening at Lilly that we should be aware of? Trying to stay ahead of things and figure out if it's time to update the resume or just chill. Let's hear what you're hearing.
Lilly - Layoffs on the horizon?
Been with Lilly for a few years now, and lately, the vibe has felt... off. Heard some chatter through the grapevine, nothing concrete, but enough to make me nervous. Project timelines seem a bit tighter, and there's been a noticeable increase in 'efficiency' discussions in leadership meetings. Wondering if anyone else is picking up on this or if it's just my team feeling the squeeze. Is it just me, or does it feel like the calm before a storm? Trying not to panic, but the uncertainty is definitely starting to wear on me. Any intel from other departments or levels would be appreciated. Just looking for some clarity or maybe some reassurance if I'm overthinking this.
Lilly - Anyone else feeling the pressure?
The atmosphere here at Lilly feels…different lately. Not outright panic, but there's definitely an undercurrent of anxiety. Performance reviews just wrapped up, and the messaging around 'efficiency' and 'strategic alignment' feels a bit heavy. I haven't seen any official layoff notices, and my team is still plugging away, but I can't shake the feeling that something's brewing. Is anyone else experiencing this? Are you seeing budget cuts, slower project approvals, or a general slowdown in new initiatives? Would love to hear if others are feeling this squeeze or if it's just my perception. Just trying to gauge if this is a company-wide thing or isolated to certain areas.
Eli Lilly - Any recent whispers about RIFs?
Hey everyone, been seeing some chatter around Lilly lately, but nothing concrete. No official announcements, no mass emails, just the usual office whispers. Anyone in R&D, manufacturing, or even commercial roles hearing anything specific? Are there particular departments that seem to be under more scrutiny or experiencing hiring freezes? I'm just trying to get a pulse on the situation as things feel a bit uncertain, even without confirmed news. Curious if anyone has insights into potential restructuring or if it's just general market noise. Trying to stay ahead of things if possible, or at least understand the general sentiment. Appreciate any honest info.
Eli Lilly - Layoff rumors vs. reality?
Okay, let's talk about it. I've seen some chatter in other pharma forums and even here about potential layoffs at Eli Lilly. Nothing confirmed, obviously, and leadership has been pretty quiet. But the speculation is definitely out there. Is anyone hearing anything specific from their managers or leadership? Are there any subtle signs like hiring freezes creeping in, or projects being shelved that weren't expected? It feels like a lot of companies are doing some kind of restructuring right now, and it's hard not to worry when you're part of a big organization. I'm in [mention a department vaguely, e.g., 'a science-focused role'] and haven't seen direct impact yet, but the anxiety is real. Anyone have solid info or just general gut feelings they want to share? Trying to separate the noise from potential truth here. How are you all managing the uncertainty?
Eli Lilly: What's the vibe on the ground?
Hey everyone, been with Lilly for a few years now and things feel… interesting. The pipeline looks great, especially with everything around Zepbound and Mounjaro. Stock's been going nuts, which is usually a good sign. But I've also been hearing whispers, same as a lot of you probably. No official word, of course, but the general economic climate and the sheer pace of innovation means companies are always evaluating. Anyone else in different departments noticing anything? Are projects being slowed down, or is it just my imagination running wild? Trying to get a pulse on whether this is just market noise or if there's something concrete we should be aware of. Curious to hear what others are seeing and hearing, especially in R&D and manufacturing. Trying to stay optimistic, but a little transparency or insight would be helpful.
Thoughts on the current Eli Lilly outlook?
Curious to hear from others at Eli Lilly. There's been a lot of buzz about our pipeline, which is great, but I'm also seeing some internal shifts that are making me a little uneasy. Hiring freezes in certain departments, whispers of budget reallocations... it's hard to tell if it's just standard business adjustments or something more significant. Especially with the economic climate and the pressure on pharma, I can't help but wonder about job security. Anyone else in different divisions noticing similar trends? Trying to stay positive about the company's future and our contributions, but it's tough when there's so much ambiguity about potential workforce changes. What's the general sentiment out there?
Eli Lilly - Anyone else feeling the jitters? Layoffs incoming?
Hey everyone, posting anonymously here because things feel a bit tense at Lilly lately. Haven't seen any official announcements or heard concrete rumors, but there's definitely a weird vibe. Some teams seem to be getting restructured, and there's been a noticeable slowdown in some project timelines. I've been here for a while and this feels different than the usual performance tweaks. Just wondering if anyone else is picking up on the same signals or has any insights? Is it just me being paranoid, or is there something brewing on the horizon? Trying not to panic, but the uncertainty is getting to me. Would appreciate any thoughts or similar experiences.
No more threads.